Nomosic

Meclizine HCl USP

Composition : Meclizine hydrochloride USP 50mg Tablet.

Indication : This tablet is indicated for the management of nausea and vomiting, and dizziness associated with motion sickness, vertigo associated with diseases affecting the vestibular system.

Dosage and administration : For the prevention and treatment of nausea, vomiting and vertigo associated with motion sickness, the usual oral dosage of meclizine hydrochloride in adults and children 12 years of age or older is 25- 50mg once daily. Vertigo : for the control of vertigo associated with diseases affecting the vestibular system, the recommended dose is 25 to 100mg daily, in divided doses, depending upon clinical response. Motion Sickness : The initial dose of 25 to 50mg should be taken one hour prior to embarkation for protection against motion sickness. Thereafter, the dose may be repeated every 24 hours for the duration of the journey.

Use in pregnancy and lactation : Pregnancy Category B by FDA.

Packing :

Nomosic Tablet : 5x10’s tablets in blister pack

Prescribing Description

Related Products

© Copyright Drug International Ltd. 2024 Designed and Developed by ATI Limited.